Skip to main content
SGHTHealthcare

Sight Sciences Inc (SGHT) Insider Trading

In the last 90 days, 5 Sight Sciences Inc (SGHT) insiders reported no open-market purchases and 5 sales totaling $652,777. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 2, 2026Brenton TaylorEVP, Operations & R&DSale2,988$8.85$26,453
Oct 2, 2026Alison BauerleinChief Operating OfficerSale25,260$8.85$223,627
Oct 2, 2026James RodbergChief Financial OfficerSale7,208$8.85$63,812
Oct 1, 2026David BadawiChief Technology OfficerSale7,797$9.05$70,555
Oct 1, 2026Paul BadawiPresident and CEOSale29,653$9.05$268,330
Jul 6, 2026Jeremy B. HaydenChief Legal OfficerSale12,733$5.51$70,133
Jul 6, 2026David BadawiChief Technology OfficerSale7,418$5.51$40,858
Jul 2, 2026James RodbergChief Financial OfficerSale6,902$5.36$36,995
Jul 2, 2026Alison BauerleinChief Operating OfficerSale24,184$5.36$129,626
Jul 1, 2026Brenton TaylorEVP, Operations & R&DSale2,829$5.42$15,333

Common questions

SGHT insider trading FAQ

Are SGHT insiders buying or selling?
Over the last 90 days, SGHT insiders were net sellers, reporting $0.00 of open-market purchases and $652,777 of sales.
When was the last SGHT insider purchase?
No open-market insider purchase of Sight Sciences Inc stock was reported in the last 90 days.
Where does SGHT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Sight Sciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.